Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often highlight the potential for substantial therapeutic outcomes, especially in diseases where conventional treatments have proven ineffective. However, this is to consider the substantial financial expenditure associated with CPI stem cel